Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Wuxi AppTec Co's share price for the quarter that ended in Dec. 2023 was ¥72.76. Wuxi AppTec Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 2,969 Mil. Therefore, Wuxi AppTec Co's market cap for the quarter that ended in Dec. 2023 was ¥216,013 Mil.
Wuxi AppTec Co's quarterly market cap
increased
from Jun. 2023 (¥184,944 Mil) to Sep. 2023 (¥255,839 Mil) but then
declined
from Sep. 2023 (¥255,839 Mil) to Dec. 2023 (¥216,013 Mil).
Wuxi AppTec Co's annual market cap
declined
from Dec. 2021 (¥350,502 Mil) to Dec. 2022 (¥239,803 Mil) and
declined
from Dec. 2022 (¥239,803 Mil) to Dec. 2023 (¥216,013 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Wuxi AppTec Co's Enterprise Value for Today is ¥116,337 Mil.
Wuxi AppTec Co Market Cap Historical Data
The historical data trend for Wuxi AppTec Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Wuxi AppTec Co's Market Cap
For the Diagnostics & Research subindustry, Wuxi AppTec Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuxi AppTec Co's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Wuxi AppTec Co's Market Cap falls into.
Wuxi AppTec Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Wuxi AppTec Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wuxi AppTec Co (SHSE:603259) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Wuxi AppTec Co Market Cap Related Terms
Thank you for viewing the detailed overview of Wuxi AppTec Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services through the discovery, development, and manufacturing spectrum for small-molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices. Its segments comprise China-based laboratory services; U.S.-based laboratory services; Clinical research and other CRO services; CDMO services; and Others. The majority of revenue gets derived from China-based laboratory services that include small molecules discovery, such as synthetic chemistry, medicinal chemistry, analytical chemistry, biology, drug metabolism and pharmacokinetics (DMPK)/absorption, distribution, metabolism, and excretion (ADME), toxicology and bioanalytical services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:603259 has been successfully added to your 